GE Healthcare Unveils Voluson SWIFT, AI-Enhanced Women’s Health Ultrasound with Industry-First Auto Recognition Tools to He...
September 30 2020 - 9:26AM
Business Wire
- Voluson SWIFT redefines the ultrasound experience for women’s
health practitioners by integrating intelligent features that can
reduce patient scanning time by as much as 45 percent and automate
exam measurements resulting in significant time savings for
users.
- World’s first ultrasound system with fully integrated AI that
recognizes the 20 views recommended by the International Society of
Ultrasound in Obstetrics and Gynecology mid-trimester practice
guidelines for fetal imaging, optimizing the scan workflow by 73
percent when compared to manual 2D workflow.1
GE Healthcare today unveiled Voluson SWIFT*, a new ultrasound
system designed to help women’s health clinicians expand diagnostic
capabilities and improve patient outcomes. The system features
industry-first AI algorithms to support auto recognition in
addition to an ergonomic design, impeccable image quality, and
tools to improve efficiency.
A recent study found that obstetrics (OB) and gynecology (GYN)
clinicians in the United States have some of the highest burnout
rates among physicians, with the leading factor being bureaucratic
tasks like paperwork, charting, and patient data capture.2 In
today’s COVID-19 pandemic environment, these clinicians are now
facing additional pressures to see more patients and perform exams
quickly to limit possible patient exposure to the coronavirus.
To help combat these constraints and improve clinical outcomes,
GE Healthcare gathered input from 200 women’s health practitioners
worldwide to develop the all-new Voluson SWIFT that is designed to
help make clinician’s daily work more manageable. New features
allow users to customize the system to their personal preferences
and the system comes with guided workflows to help new users learn
the technology faster and use it more effectively.
“The Voluson SWIFT is intuitive to use and comes with many
options to personalize your preferences on the system and
auto-measurement tools that allow you to focus on the examination
rather than time-consuming adjustments,” said Dr. Ralf Menkhaus,
Gynecologist at Kinderwunschzentrum in Minden, Germany. “It’s like
the machine is helping do some of the thinking for you which has
allowed me to seamlessly integrate it for any obstetric and
gynecological exams I need to do.”
The Voluson SWIFT ultrasound system features an embedded
artificial intelligence platform, including the new SonoLyst**
application, the industry’s first fully integrated AI tool that
recognizes the 20 views recommended by the International Society of
Ultrasound in Obstetrics and Gynecology mid-trimester practice
guidelines for fetal imaging, optimizing the scan workflow by 73
percent when compared to manual 2D workflow. Additional benefits
include:
- Scan Assistant tool that guides clinicians through protocols
and reduces the patient scanning time by up to 45 percent, with
simplified workflow and freedom to customize and create your own
user protocols.3,4
- SonoBiometry measurements are now 38 percent faster than
previous platforms and three additional measurements to
SonoBiometry make Voluson SWIFT 60 percent more automated than
previous systems.5
- Utilizing SonoCNS, developed on GE Healthcare’s Edison
intelligence platform, on the Voluson SWIFT can help reduce
keystrokes by 78 percent when obtaining desired planes and
measurements of the fetal central nervous system (CNS).6
“Voluson SWIFT has redefined one of the most essential
tools obstetrics and gynecology clinicians rely on, delivering a
contemporary design, intuitive user interface, and intelligent
workflow supported by AI,” said Roland Rott, General Manager of
Women’s Health Ultrasound at GE Healthcare. “In today’s environment
where cleanliness and time savings opportunities are critical for
clinicians, we’re proud to offer a solution that makes our
customers’ work easier and gives them time back with their
patients.”
To learn more about GE Healthcare’s Voluson SWIFT technology,
click here.
*510(k) pending at FDA. Not available for sale in the United
States.
**SonoLyst incorporates the AI technology of Intelligent
Ultrasound
About GE Healthcare
GE Healthcare is the $16.7 billion healthcare business of GE
(NYSE: GE). As a leading global medical technology and digital
solutions innovator, GE Healthcare enables clinicians to make
faster, more informed decisions through intelligent devices, data
analytics, applications and services, supported by its Edison
intelligence platform. With over 100 years of healthcare industry
experience and around 50,000 employees globally, the company
operates at the center of an ecosystem working toward precision
health, digitizing healthcare, helping drive productivity and
improve outcomes for patients, providers, health systems and
researchers around the world.
Follow us on Facebook, LinkedIn, Twitter, Instagram and Insights
for the latest news, or visit our website www.gehealthcare.com for
more information.
1 Comparison performed using GE Healthcare’s Voluson SWIFT/
SWIFT+ compared to Voluson P8.
2 Accessed on 9/22/2020:
https://www.medscape.com/slideshow/2020-lifestyle-obgyn-6012501
3 Comparison performed using GE’s Voluson SWIFT/ SWIFT+ vs.
Voluson P8.
4 Comparison performed using GE’s Voluson SWIFT/ SWIFT+ vs.
Voluson P8 BT18 & Voluson S6 BT16.
5 Comparison performed using GE’s Voluson SWIFT/SWIFT+ and GE’s
Voluson P8 BT18.
6 Sonographic examination of the fetal central nervous system:
guidelines for performing the „basic examination“ and the „fetal
neurosonogram“ [Ultrasound Obstet. Gynecol. 2007; 29: 109–116]
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200930005576/en/
Kate Rodgers GE Healthcare +1 815 388 5697
Katlynn.Rodgers@ge.com
GE Aerospace (NYSE:GE)
Historical Stock Chart
From Mar 2024 to Apr 2024
GE Aerospace (NYSE:GE)
Historical Stock Chart
From Apr 2023 to Apr 2024